Department of Burn and Plastic Surgery, The First Hospital of Hebei Medical University, Shijiazhuang, China.
Int Wound J. 2023 May;20(5):1393-1401. doi: 10.1111/iwj.13987. Epub 2022 Nov 6.
To explore the curative effect of insulin external application on burn wounds of diabetic patients with different depths. A retrospective analysis of 114 diabetic burn patients in the First Hospital of Hebei Medical University from June 2019 to June 2022. According to the different treatment methods, they were divided into study group (insulin therapy) and control group (conventional therapy) with 57 cases in each. The wound healing time, dressing changes, scar healing after wound healing and adverse events were compared between two groups. Pain level, serum inflammatory factors, vascular endothelial growth factor (VEGF) and oxidative stress factors before and after treatment were compared. The wound healing time (17.23 ± 2.18 vs 20.31 ± 2.09 days) and the number of dressing changes (7.01 ± 1.23 vs 8.93 ± 1.32 times) in study group were significantly lower than those in control group (P < 0.05). Before treatment, there was no difference in pain level, VEGF, interleukin-1 (IL-1), tumour necrosis factor-α (TNF-α), malondialdehyde (MDA) and superoxide dismutase (SOD) between two groups (P > 0.05). However, the pain level, scar healing, IL-1, TNF-a and MDA in study group were significantly lower than those in control group after treatment (P < 0.05). And the VEGF and SOD in study group was significantly higher than that in control group (P < 0.05). External application of insulin can shorten the wound healing time of diabetic patients with different depths, reduce the number of dressing changes, promote scar healing after wound healing, relieve pain and reduce the level of inflammatory factors, which is worthy of clinical promotion.
探讨胰岛素外用对不同深度糖尿病患者烧伤创面的疗效。回顾性分析 2019 年 6 月至 2022 年 6 月河北医科大学第一医院收治的 114 例糖尿病烧伤患者,根据不同治疗方法分为观察组(胰岛素治疗)和对照组(常规治疗),每组 57 例。比较两组患者的创面愈合时间、换药次数、创面愈合后瘢痕愈合情况及不良反应。比较两组患者治疗前后疼痛程度、血清炎症因子、血管内皮生长因子(VEGF)及氧化应激因子。观察组创面愈合时间(17.23±2.18 天)、换药次数(7.01±1.23 次)明显低于对照组(20.31±2.09 天、8.93±1.32 次)(P<0.05)。治疗前,两组患者疼痛程度、VEGF、白细胞介素-1(IL-1)、肿瘤坏死因子-α(TNF-α)、丙二醛(MDA)、超氧化物歧化酶(SOD)水平比较差异无统计学意义(P>0.05)。治疗后观察组疼痛程度、瘢痕愈合、IL-1、TNF-α、MDA 水平明显低于对照组(P<0.05),VEGF、SOD 水平明显高于对照组(P<0.05)。胰岛素外用可缩短不同深度糖尿病患者的创面愈合时间,减少换药次数,促进创面愈合后瘢痕愈合,缓解疼痛,降低炎症因子水平,值得临床推广。